Dr. Thomas is helping lead the HCV Elimination Program in Florida.

The FL HCV elimination group convened national and local experts in August 2019 in Orlando, FL for its inaugural meeting to address screening, treatment-level barriers and liver cancer prevention. The meeting goal was to support a statewide HCV elimination program and it was attended by stakeholders including representatives from the FL DOH, patients, medical and social service providers, researchers, policymakers and others from private organizations. This followed an earlier HCV elimination meeting in February 2019, held in Miami, FL by the major liver disease societies (AASLD/EASL). Planned activities will strengthen and be synergistic with the current efforts from the FL DOH viral hepatitis program and include involvement of four major academic centers in FL. Stakeholders will continue to meet in 2020 with the goal of producing a guidance document with…
Read More

Dr. Thomas presented in the Antibody Testing and Treatment Recommendations webinar as part of the AASLD’s ongoing series.

Dr. Thomas presented in the Antibody Testing and Treatment Recommendations webinar hosted by the American Association for the Study of Liver Diseases. The webinar took place on April 30th, 2020 as part of the COVID-19 and the Liver series by the AASLD COVID-19 Working Group. The COVID-19 and the Liver series is dedicated to presenting discoveries and discussions about COVID-19 and how it impacts the care of liver patients. The Antibody Testing and Treatment Recommendations webinar is the fourth in the series. This session was designed to: Describe updates to the COVID-19 pandemic's effect on the liver and its impact on hepatology and liver transplant providers.Help attendees to understand and review management strategies in patients with COVID-19 and chronic liver disease.Provide information regarding diagnostic antibody tests for SARS-CoV-2 exposure and…
Read More